The Operation of International Trade-Related Intellectual Property Barriers in the Context of Human Rights and Access to Medicines During the COVID-19 Pandemic

Abstract

The worldwide COVID-19 outbreak has re-ignited the discussion over people's ability to get their hands on necessary medications. To achieve public health indicators, it is necessary to ensure that drugs may be freely obtained. A feature of the Indian health system is the availability of affordable and effective medications for a broad range of requirements, despite the fact that public investment on health is very low in India. India became known as the "pharmacy of the world" because to the low costs charged by pharmaceutical businesses like Serum Institute of India, Biological E, Dr. Reddy's, etc., which produced and provided critically important medications.